Company announcement No. 44
Fredericia,
The subsidiary Watgen Medical A/S, has obtained a patent for a device for topical treatment.
The patent supports the companys innovative development of new water treatment
technology for the treatment of inflammation and wounds.
Topical means on the body surface, ie. on the skin, in the nasal opening, in the eyes, in the
ears, in the rectal opening and the vagina.
states:
“the markets Watgen Medical A/S focuses on are today controlled by large global
companies and it is therefore of great importance to Watgen Medical that it has succeeded in
achieving a broad patent, which the company can potentially also license to existing
companies in the industry ”.
Watgen Medical has previously announced a plan to conduct a IPO in 2021.
About
technology for heating or treating water, with the focus on ensuring bacteria-free water and
reducing water and energy consumption for heating hot water in properties and thus ensuring
CO2 savings.
Medical A/S and in the technology company Aquaturu A/S.
Further information:
CEO
Sjællandsgade 32
7100 Vejle
Certified Adviser
Christian IX Gade 7, 3 rd ,
1111 København
Phone.: +45 71961030
Contact:
Website: toftecompany.com
Nasdaq First North Growth Market
Important links:
Websites:
www.waturu.com
www.aquaturu.com
www.watgenmedical.com
Financial reports:
www.waturu.com/documents
Further press related news:
www.linkedin.com/company/waturu/
www.facebook.com/WaturuDenmark/
© OMX, source